Pharmaceutical company JB Chemicals and Pharmaceuticals Ltd announced on Tuesday (March 24) the appointment of Aman Mehta as managing director for a three-year term, effective January 21, 2026.
Currently, Mehta serves as Managing Director at Torrent Pharmaceuticals Limited. He holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University in New York. With over a decade of experience in strategic growth, M&A integration, and market expansion, he brings a wealth of knowledge to this new role.
Mehta has played a key role in accelerating growth at Torrent Pharma, utilizing both organic initiatives and strategic acquisitions. His major contributions include identifying and integrating assets for M&A (such as Unichem and Curatio) and driving organic growth in the Indian market, primarily through field force expansion, in-licensing, and entering new therapeutic areas.
Also Read: Torrent Pharma shares rise 4% following steady Q3; Analysts optimistic about JB merger advantages
In addition, JB Chemicals appointed four non-executive, non-independent directors: Amal Kelshikar, Hasmukh Patel, and Sudhir Menon, along with Aman Mehta, all taking effect on March 23, 2026.
Amal Kelshikar brings 32 years of experience in strategic planning, marketing, sales, and licensing. He earned a BE (Chem) from the University Department of Chemical Technology, Mumbai, and an MBA (PGDM) from the Indian Institute of Management, Ahmedabad, along with executive training from Harvard Business School and Kellogg Executive Education.
Hasmukh Patel, who has over 33 years of experience in the pharmaceutical industry, has held senior leadership positions at Torrent Pharmaceuticals focusing on manufacturing, supply chain, API development, and product development. He holds a master’s degree in pharmacy.
Also Read: JB Chemicals and Pharma Q3 Results: Profit up 22% as domestic business outperforms market
Sudhir Menon, a chartered and cost accountant, brings 29 years of finance and corporate management experience. He currently serves as the executive director (finance) and CFO at Torrent Pharmaceuticals Limited, overseeing finance, legal, IT, and investor relations.
On March 24, shares of JB Chemicals and Pharmaceuticals Ltd closed at ₹2,071.80, down by ₹11.05, or 0.53%, on the BSE.
